Phase 1 and pharmacologic study of MS-275, a histone deacetylase inhibitor, in adults with refractory and relapsed acute leukemias

MS-275 is a benzamide derivative with potent histone deacetylase (HDAC) inhibitory and antitumor activity in preclinical models. We conducted a phase 1 trial of orally administered MS-275 in 38 adults with advanced acute leukemias. Cohorts of patients were treated with MS-275 initially once weekly ×...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: Gojo, Ivana, Jiemjit, Anchalee, Trepel, Jane B., Sparreboom, Alex, Figg, William D., Rollins, Sandra, Tidwell, Michael L., Greer, Jacqueline, Chung, Eun Joo, Lee, Min-Jung, Gore, Steven D., Sausville, Edward A., Zwiebel, James, Karp, Judith E.
Formáid: Artigo
Teanga:Inglês
Foilsithe: American Society of Hematology 2007
Ábhair:
Clinical Trials and Observations
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1852211/
https://ncbi.nlm.nih.gov/pubmed/17179232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-05-021873
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla